Latest Cadence Stories

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's management will present a corporate overview at the following investment conferences during the month of May: Bank of America Merrill Lynch 2013 Health Care Conference at the Encore at the Wynn Hotel in Las...

Leading RIM consulting firm teams with global, non-profit association to create unique learning opportunity. Atlanta, GA (PRWEB) May 02, 2013 Starting on Tuesday, June 18, 2013, Cadence Group will host a four-day AIIM Electronic Records Management (ERM) Master Classroom Course and a two-day ERM Practitioner Classroom Course. Each course promises to provide a unique opportunity for human resources, information technology, finance, and legal professionals in the southeastern U.S. to gain...

SAN DIEGO, April 25, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its first quarter ended March 31, 2013 financial results on Thursday, May 2, 2013. Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, May 2,...

The brand new Panobike Bluetooth Smart speed and cadence sensor is available at the Heart Rate Watch Company just in time for Spring cycling. Bozeman, MT (PRWEB) March 22, 2013 The new Panobike Bluetooth Smart speed and cadence sensor is now being offered at the Heart Rate Watch Company for $43.96. "We are quite excited because this is 36% less expensive than the Wahoo Blue Speed and Cadence Sensor, so it clearly offers our customers a better deal for a device that delivers the same...

Thought leader will join Seth Godin, David Pogue and David Weinberger in exploring questions around extreme information Atlanta, GA (PRWEB) March 13, 2013 Cadence Group®, an information and records management firm based in Atlanta and Washington D.C., is pleased to announce that CEO Tina Teree Baker will be speaking at the 2013 AIIM Conference to be held in New Orleans on March 20-22, 2013. This year’s conference centers on the concept of extreme knowledge with tracks in...

SAN DIEGO, March 6, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags. Previously, Cadence announced the...

SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Tuesday, March 5, 2013 at 11:20am Eastern Time (8:20am Pacific Time) during the Cowen & Company 33(rd) Annual...

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a preliminary (unaudited) estimate of net product revenue from sales of OFIRMEV(®) (acetaminophen) injection for the three-months ended December 31, 2012, of approximately $17.1 million. "We ended 2012 on a high note, with...

WINFIELD, Ill., Dec. 13, 2012 /PRNewswire-USNewswire/ -- Cadence Health, the health system created through the merger of Central DuPage Health and Delnor Community Health System, announced today that Chris Hensley has been appointed President of the Cadence Health Foundation. Mr. Hensley is the first President of the Cadence Health Foundation, which was formed following the merger of the CDH Foundation and Delnor Foundation. (Photo:...

SAN DIEGO, Calif., Dec. 12, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that it has entered into an agreement to terminate its exclusive option to acquire privately-held Incline Therapeutics, Inc., or Incline. Under the waiver, consent and option termination agreement signed by Cadence...